Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 12.61% on an annualized basis producing an average annual return of 21.37%. Currently, Regeneron Pharmaceuticals has a market capitalization of $82.15 billion.
Buying $1000 In REGN: If an investor had bought $1000 of REGN stock 20 years ago, it would be worth $45,380.21 today based on a price of $781.67 for REGN at the time of writing.
Regeneron Pharmaceuticals’s Performance Over Last 20 Years

Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Recent Comments